134 related articles for article (PubMed ID: 9794720)
1. Modulation of vasoconstriction by insulin.
van Veen S; Chang PC
J Hypertens; 1998 Aug; 16(8):1157-64. PubMed ID: 9794720
[TBL] [Abstract][Full Text] [Related]
2. Neurovascular dissociation with paradoxical forearm vasodilation during systemic tyramine administration.
Jacob G; Costa F; Vincent S; Robertson D; Biaggioni I
Circulation; 2003 May; 107(19):2475-9. PubMed ID: 12707242
[TBL] [Abstract][Full Text] [Related]
3. Glargine and regular human insulin similarly acutely enhance endothelium-dependent vasodilatation in normal subjects.
Westerbacka J; Bergholm R; Tiikkainen M; Yki-Järvinen H
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):320-4. PubMed ID: 14656737
[TBL] [Abstract][Full Text] [Related]
4. Acute hyperglycemia and hyperinsulinemia enhance adrenergic vasoconstriction and decrease calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
Zamami Y; Takatori S; Yamawaki K; Miyashita S; Mio M; Kitamura Y; Kawasaki H
Hypertens Res; 2008 May; 31(5):1033-44. PubMed ID: 18712059
[TBL] [Abstract][Full Text] [Related]
5. Vascular effects of endothelin-1 in humans and influence of calcium channel blockade.
Kiowski W; Linder L; Erne P
J Hypertens Suppl; 1994 Jan; 12(1):S21-6. PubMed ID: 8207561
[TBL] [Abstract][Full Text] [Related]
6. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
[TBL] [Abstract][Full Text] [Related]
7. Insulin modulation of beta-adrenergic vasodilator pathway in human forearm.
Lembo G; Iaccarino G; Vecchione C; Rendina V; Parrella L; Trimarco B
Circulation; 1996 Apr; 93(7):1403-10. PubMed ID: 8641030
[TBL] [Abstract][Full Text] [Related]
8. Prolonged local forearm hyperinsulinemia induces sustained enhancement of nitric oxide-dependent vasodilation in healthy subjects.
Hermann TS; Ihlemann N; Dominguez H; Rask-Madsen C; Kober L; Torp-Pedersen C
Endothelium; 2004; 11(5-6):231-9. PubMed ID: 15763942
[TBL] [Abstract][Full Text] [Related]
9. Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide.
Passauer J; Pistrosch F; Büssemaker E; Lässig G; Herbrig K; Gross P
J Am Soc Nephrol; 2005 Apr; 16(4):959-65. PubMed ID: 15728785
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans.
Rask-Madsen C; Domínguez H; Ihlemann N; Hermann T; Køber L; Torp-Pedersen C
Circulation; 2003 Oct; 108(15):1815-21. PubMed ID: 14530204
[TBL] [Abstract][Full Text] [Related]
11. Chronic hyperinsulinemia enhances adrenergic vasoconstriction and decreases calcitonin gene-related peptide-containing nerve-mediated vasodilation in pithed rats.
Takatori S; Zamami Y; Mio M; Kurosaki Y; Kawasaki H
Hypertens Res; 2006 May; 29(5):361-8. PubMed ID: 16832157
[TBL] [Abstract][Full Text] [Related]
12. Role of adenosine A(1) receptor in angiotensin II- and norepinephrine-induced renal vasoconstriction.
Aki Y; Nishiyama A; Miyatake A; Kimura S; Kohno M; Abe Y
J Pharmacol Exp Ther; 2002 Oct; 303(1):117-23. PubMed ID: 12235241
[TBL] [Abstract][Full Text] [Related]
13. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide.
Affolter JT; McKee SP; Helmy A; Jones CR; Newby DE; Webb DJ
Clin Pharmacol Ther; 2003 Jul; 74(1):9-16. PubMed ID: 12844130
[TBL] [Abstract][Full Text] [Related]
14. Insulin blunts sympathetic vasoconstriction through the alpha 2-adrenergic pathway in humans.
Lembo G; Iaccarino G; Rendina V; Volpe M; Trimarco B
Hypertension; 1994 Oct; 24(4):429-38. PubMed ID: 7916334
[TBL] [Abstract][Full Text] [Related]
15. Dietary sodium intake modulates systemic but not forearm norepinephrine release.
Stein CM; Nelson R; Brown M; He H; Wood M; Wood AJ
Clin Pharmacol Ther; 1995 Oct; 58(4):425-33. PubMed ID: 7586935
[TBL] [Abstract][Full Text] [Related]
16. Exogenous NO administration and alpha-adrenergic vasoconstriction in human limbs.
Rosenmeier JB; Fritzlar SJ; Dinenno FA; Joyner MJ
J Appl Physiol (1985); 2003 Dec; 95(6):2370-4. PubMed ID: 12923119
[TBL] [Abstract][Full Text] [Related]
17. On the existence of functional beta-adrenoceptors on vascular sympathetic nerve endings in the human forearm.
Chang PC; Grossman E; Kopin IJ; Goldstein DS
J Hypertens; 1994 Jun; 12(6):681-90. PubMed ID: 7963493
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia.
Pickkers P; Dorresteijn MJ; Bouw MP; van der Hoeven JG; Smits P
Circulation; 2006 Aug; 114(5):414-21. PubMed ID: 16864730
[TBL] [Abstract][Full Text] [Related]
19. Circulating ATP-induced vasodilatation overrides sympathetic vasoconstrictor activity in human skeletal muscle.
Rosenmeier JB; Hansen J; González-Alonso J
J Physiol; 2004 Jul; 558(Pt 1):351-65. PubMed ID: 15155791
[TBL] [Abstract][Full Text] [Related]
20. 3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes.
Vehkavaara S; Yki-Järvinen H
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):325-30. PubMed ID: 14684428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
